Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Maiese K.

Curr Neurovasc Res. 2018;15(1):81-91. doi: 10.2174/1567202615666180319151244. Review.


Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

Maiese K.

Curr Neurovasc Res. 2017;14(3):299-304. doi: 10.2174/1567202614666170718092010. Review.


Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.

Maiese K.

Curr Neurovasc Res. 2017;14(4):415-420. doi: 10.2174/1567202614666171116102911. Review.


Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Maiese K.

Curr Neurovasc Res. 2017;14(1):82-88. doi: 10.2174/1567202613666161129112822. Review.


Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Maiese K.

Br J Clin Pharmacol. 2016 Nov;82(5):1245-1266. doi: 10.1111/bcp.12804. Epub 2015 Dec 26. Review.


FoxO proteins in the nervous system.

Maiese K.

Anal Cell Pathol (Amst). 2015;2015:569392. doi: 10.1155/2015/569392. Epub 2015 Jun 10. Review.


Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.

Maiese K.

Neural Regen Res. 2016 Mar;11(3):372-85. doi: 10.4103/1673-5374.179032. Review.


MicroRNAs and SIRT1: A Strategy for Stem Cell Renewal and Clinical Development?

Maiese K.

J Transl Sci. 2015 Nov;1(3):55-57. Epub 2015 Oct 8.


Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.

Maiese K.

Curr Neurovasc Res. 2017;14(2):184-189. doi: 10.2174/1567202614666170313105337. Review.


Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Maiese K.

Curr Neurovasc Res. 2018 Nov 28. doi: 10.2174/1567202616666181128120003. [Epub ahead of print]


Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson's Disease.

Wang Y, Lv D, Liu W, Li S, Chen J, Shen Y, Wang F, Hu LF, Liu CF.

Oxid Med Cell Longev. 2018 Apr 18;2018:4854732. doi: 10.1155/2018/4854732. eCollection 2018.


SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.

Maiese K.

World J Stem Cells. 2015 Mar 26;7(2):235-42. doi: 10.4252/wjsc.v7.i2.235.


The "O" class: crafting clinical care with FoxO transcription factors.

Maiese K, Chong ZZ, Hou J, Shang YC.

Adv Exp Med Biol. 2009;665:242-60. Review.


FOXO in Neural Cells and Diseases of the Nervous System.

Santo EE, Paik J.

Curr Top Dev Biol. 2018;127:105-118. doi: 10.1016/bs.ctdb.2017.10.002. Epub 2018 Feb 3. Review.


Identification of a novel circadian clock modulator controlling BMAL1 expression through a ROR/REV-ERB-response element-dependent mechanism.

Lee J, Lee S, Chung S, Park N, Son GH, An H, Jang J, Chang DJ, Suh YG, Kim K.

Biochem Biophys Res Commun. 2016 Jan 15;469(3):580-6. doi: 10.1016/j.bbrc.2015.12.030. Epub 2015 Dec 12.


Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.

Maiese K, Chong ZZ, Wang S, Shang YC.

Int J Mol Sci. 2012 Oct 26;13(11):13830-66. doi: 10.3390/ijms131113830. Review.


Abrogation of the Circadian Nuclear Receptor REV-ERBĪ± Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration.

Kim J, Jang S, Choi M, Chung S, Choe Y, Choe HK, Son GH, Rhee K, Kim K.

Mol Cells. 2018 Aug 31;41(8):742-752. doi: 10.14348/molcells.2018.0201. Epub 2018 Jul 30.


Regeneration in the nervous system with erythropoietin.

Maiese K.

Front Biosci (Landmark Ed). 2016 Jan;21(3):561-596.

Supplemental Content

Support Center